Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk factors for Alzheimer’s disease
Richard A. Armstrong
Folia Neuropathologica (2019) Vol. 57, Iss. 2, pp. 87-105
Open Access | Times Cited: 468

Showing 51-75 of 468 citing articles:

Genomic stress and impaired DNA repair in Alzheimer disease
Jolien Neven, Luidy Kazuo Issayama, Ilse Dewachter, et al.
DNA repair (2024) Vol. 139, pp. 103678-103678
Closed Access | Times Cited: 9
MicroRNAs and synapse turnover in Alzheimer’s disease
Sarthak Dalal, Jaime Ramirez-Gomez, Bhupender Sharma, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102377-102377
Closed Access | Times Cited: 9
The Role of Oligodendrocyte Lineage Cells in the Pathogenesis of Alzheimer’s Disease
Xiaodong Liu, Zhe Lv, Qin Huang, et al.
Neurochemical Research (2025) Vol. 50, Iss. 1
Closed Access | Times Cited: 1
A matched case-control study on polypharmacy and co-medications one year before drug treatment for Alzheimer's disease
Ali Alghamdi, Stijn de Vos, Jens H. J. Bos, et al.
Journal of Alzheimer s Disease (2025)
Closed Access | Times Cited: 1
Integrated Multi-Omics Analyses of Synaptosomes Revealed Synapse-Centered Novel Targets in Alzheimer's Disease
Subodh Kumar, Enrique Ramos, Axel M. Hidalgo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access | Times Cited: 1
The impact of genetic variability on Alzheimer’s therapies: obstacles for pharmacogenetic progress
Ramón Cacabelos, Olaia Martínez-Iglesias, Natalia Cacabelos, et al.
Expert Opinion on Drug Metabolism & Toxicology (2025), pp. 1-28
Closed Access | Times Cited: 1
Bioactive peptides as multipotent molecules bespoke and designed for Alzheimer's disease
Ana Mesias, Sandra Borges, Manuela Pintado, et al.
Neuropeptides (2025) Vol. 111, pp. 102515-102515
Closed Access | Times Cited: 1
Biofilm-Associated Amyloid Proteins Linked with the Progression of Neurodegenerative Diseases
Alka Ashok Singh, Fazlurrahman Khan, Minseok Song
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2695-2695
Open Access | Times Cited: 1
Alzheimer’s Disease: Etiology, Neuropathology and Pathogenesis
Olivia Sheppard, Michael P. Coleman
Exon Publications eBooks (2020), pp. 1-22
Open Access | Times Cited: 63
The Increased Densities, But Different Distributions, of Both C3 and S100A10 Immunopositive Astrocyte-Like Cells in Alzheimer’s Disease Brains Suggest Possible Roles for Both A1 and A2 Astrocytes in the Disease Pathogenesis
Andrew King, Boglarka Szekely, Eda Calapkulu, et al.
Brain Sciences (2020) Vol. 10, Iss. 8, pp. 503-503
Open Access | Times Cited: 60
Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease
Ida Manna, Selene De Benedittis, Andrea Quattrone, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 9, pp. 243-243
Open Access | Times Cited: 56
Aluminum impairs cognitive function by activating DDX3X-NLRP3-mediated pyroptosis signaling pathway
Wudi Hao, Chenyu Hao, Chengrong Wu, et al.
Food and Chemical Toxicology (2021) Vol. 157, pp. 112591-112591
Closed Access | Times Cited: 55
Dysregulation of Astrocyte–Neuronal Communication in Alzheimer’s Disease
Carmen Nanclares, Andrés M. Baraibar, Alfonso Araque, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7887-7887
Open Access | Times Cited: 47
Pathophysiology of Alzheimer’s Disease
Brandon C. Yarns, Kelsey A. Holiday, David M. Carlson, et al.
Psychiatric Clinics of North America (2022) Vol. 45, Iss. 4, pp. 663-676
Closed Access | Times Cited: 38
Advances on Therapeutic Strategies for Alzheimer’s Disease: From Medicinal Plant to Nanotechnology
Nasser A. Hassan, Asma K. Alshamari, Allam A. Hassan, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4839-4839
Open Access | Times Cited: 34
The Bioactivities of Phycocyanobilin from Spirulina
Yi Li
Journal of Immunology Research (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 33
Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders
Маргарита Е. Неганова, Yulia Aleksandrova, Olga Sukocheva, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 805-833
Closed Access | Times Cited: 29
Targeting Alzheimer’s Disease: The Critical Crosstalk between the Liver and Brain
Zhihai Huang, Hung Wen Lin, Quanguang Zhang, et al.
Nutrients (2022) Vol. 14, Iss. 20, pp. 4298-4298
Open Access | Times Cited: 29
Photobiomodulation in Alzheimer’s Disease—A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?
Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 916-916
Open Access | Times Cited: 22
Implications of gut and oral microbiota in neuroinflammatory responses in Alzheimer's disease
Laura Bello-Corral, Lisa Alves-Gomes, Jesús Antonio Fernández-Fernández, et al.
Life Sciences (2023) Vol. 333, pp. 122132-122132
Open Access | Times Cited: 22
Exploration of novel biomarkers in Alzheimer’s disease based on four diagnostic models
Cuihua Zou, Li Su, Mika Pan, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 19
Enhancing the Therapeutic Effect in Alzheimer's Disease Drugs: The role of Polypharmacology and Cholinesterase inhibitors
M. Margarida Martins, Paula S. Branco, Luı́sa M. Ferreira
ChemistrySelect (2023) Vol. 8, Iss. 10
Open Access | Times Cited: 19
Emerging Roles of Cells and Molecules of Innate Immunity in Alzheimer’s Disease
Bartolo Tamburini, Giusto Davide Badami, Marco Pio La Manna, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 11922-11922
Open Access | Times Cited: 19
The novel function of bexarotene for neurological diseases
Yangtao Liu, Pengwei Wang, Guofang Jin, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102021-102021
Closed Access | Times Cited: 17
The immunomodulatory effects of mesenchymal stem cell-derived extracellular vesicles in Alzheimer's disease
Yang Ye, Mingzhu Gao, Wentao Shi, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 8

Scroll to top